MATINAS BIOPHARMA HOLDINGS, INC. Available-for-sale Securities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Available-for-sale Securities of $29.49 million as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2021-08-10
- 2021-06-30: Available-for-sale Securities $29.49M.
- 2021-03-31: Available-for-sale Securities $37.28M.
- 2020-12-31: Available-for-sale Securities $46.25M.
- 2020-09-30: Available-for-sale Securities $55.72K.
| Period end | Available-for-sale Securities |
|---|---|
| 2021-06-30 | $29.49M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $37.28M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $46.25M 10-Q · filed 2021-08-10 |
| 2020-09-30 | $55.72K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $53.05K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $61.09K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.61M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |